Stuttgart - Delayed Quote EUR

Animalcare Group plc (WQ7.SG)

3.1000
+0.1000
+(3.33%)
As of 9:17:18 AM GMT+2. Market Open.
Loading Chart for WQ7.SG
  • Previous Close 3.0000
  • Open 3.1600
  • Bid 3.1000 x --
  • Ask 3.5600 x --
  • Day's Range 3.1000 - 3.1600
  • 52 Week Range 2.2200 - 3.3800
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 216.81M
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 34.44
  • EPS (TTM) 0.0900
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 0.06 (1.99%)
  • Ex-Dividend Date Jun 19, 2025
  • 1y Target Est --

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company operates in Belgium, the Netherlands, the United Kingdom, Germany, Spain, Italy, Portugal, Asia, the Middle East, Africa, European Union, and internationally. Animalcare Group plc is based in York, the United Kingdom.

www.animalcaregroup.com

201

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WQ7.SG

View More

Performance Overview: WQ7.SG

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

WQ7.SG
12.32%
FTSE 100 (^FTSE)
7.14%

1-Year Return

WQ7.SG
16.05%
FTSE 100 (^FTSE)
6.39%

3-Year Return

WQ7.SG
3.73%
FTSE 100 (^FTSE)
15.22%

5-Year Return

WQ7.SG
9.36%
FTSE 100 (^FTSE)
44.11%

Compare To: WQ7.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WQ7.SG

View More

Valuation Measures

Annual
As of 5/28/2025
  • Market Cap

    220.37M

  • Enterprise Value

    234.02M

  • Trailing P/E

    32.05

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.08

  • Price/Book (mrq)

    1.52

  • Enterprise Value/Revenue

    2.65

  • Enterprise Value/EBITDA

    14.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    24.92%

  • Return on Assets (ttm)

    2.14%

  • Return on Equity (ttm)

    5.04%

  • Revenue (ttm)

    74.23M

  • Net Income Avi to Common (ttm)

    4.82M

  • Diluted EPS (ttm)

    0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.71M

  • Total Debt/Equity (mrq)

    20.44%

  • Levered Free Cash Flow (ttm)

    -52.25M

Research Analysis: WQ7.SG

View More

Company Insights: WQ7.SG

Research Reports: WQ7.SG

View More

People Also Watch